Athira Pharma Deal History & Licensing Activity
Athira Pharma is a biotech headquartered in Israel. Over the past three years, Athira Pharma has been involved in 1 licensing and acquisition transaction, with a primary focus on Small Molecules (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Small Molecules
Focus Area
Oncology
Athira Pharma Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Athira Pharma in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| lasofoxifene | Athira Pharma, Inc. | Small Molecules | Phase 3 | license | Dec 2025 |
Athira Pharma Pipeline Focus
Therapeutic areas and modalities where Athira Pharma is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Athira Pharma Strategic Signals
Key indicators of Athira Pharma's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
See How Your Asset Matches Athira Pharma's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Oncology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Oncology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for oncology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Athira Pharma Licensing & Deal Activity
Athira Pharma is a biotech company based in Israel that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Athira Pharma ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Athira Pharma include Oncology (2 deals and trials). In terms of modality, Athira Pharma has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Athira Pharma and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Athira Pharma's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.